Alveo Technologies
PrivateLast Round
Grant
May 26, 2026
Total Funding Raised
$60.85M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Alveo Technologies is a biotechnology company that develops a portable, point-of-need molecular diagnostic platform for the rapid detection of infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Environmental Monitoring, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS, Government Contracts, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alveo Technologies Comparables
Compare Alveo Technologies with similar companies based on industry and business-model similarity.
Alveo Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 26, 2026 | ||||
| Series A Extension | Apr 29, 2025 | ||||
| Grant | Nov 14, 2024 | ||||
| Series B | Aug 1, 2023 | ||||
| VC Round | Mar 29, 2021 | ||||
Grant | Mar 17, 2021 |
Alveo Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Centers for Disease Control and Prevention | Grant |
| CEPI | Grant |
| H. Barton Asset Management | Series A Extension |
| Khosla Ventures | Grant |
| WRVI Capital | Series A, Series A Extension |
| Supply Change Capital | Series A Extension |
| Bill & Melinda Gates Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 122, 21.8x the trailing average.
- Apr 29, 2025
Raised Series A Extension with Black Diamond Ventures, H. Barton Asset Management, WRVI Capital, and Supply Change Capital.
Recent news
Latest coverage and updates
- partners_withSep 22, 2026
Alveo Technologies, Inc. partnered with Gdanimalhealth on Sep 22nd '26.
- partners_withSep 14, 2026
Alveo Technologies, Inc. partnered with AGBL Group on Sep 14th '26.
- is_developingAug 26, 2026
Alveo Technologies, Inc. is developing H5N1 Surveillance System on Aug 26th '26.
- is_developingAug 25, 2026
Alveo Technologies, Inc. is developing early warning system for avian flu on Aug 25th '26.
- partners_withAug 25, 2026
Alveo Technologies, Inc. partnered with AgriNerds Inc. on Aug 25th '26.
Alveo Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Alveo Technologies's valuation, stock price, and market status.
Is Alveo Technologies a public or private company?
Alveo Technologies is a private company.
What is the current stock price of Alveo Technologies?
Alveo Technologies is a private company with no public stock price. No recent secondary market data is available.
How much is Alveo Technologies worth (valuation)?
Valuation information for Alveo Technologies is not publicly available.
Can I buy Alveo Technologies stock?
Alveo Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Alveo Technologies's last funding round?
Alveo Technologies's most recent funding round was VC Round on March 29, 2021.
Who are the main investors in Alveo Technologies?
Key investors in Alveo Technologies include Maxim Group.
Will Alveo Technologies IPO soon?
No public IPO plans have been announced for Alveo Technologies.
How can I track Alveo Technologies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alveo Technologies's secondary market activity and sign up for updates.